Fenwick & West has advised Star Therapeutics on the transaction, while Goodwin Procter has advised Incyte. Star Therapeutics and Incyte have announced a definitive agreement in...
Incyte to Acquire Vega Therapeutics from Star Therapeutics for Up to $2 Billion
BioAge Labs Completes $115 Million Upsized Public Offering
Fenwick & West has advised BioAge Labs, Inc. Cooley LLP has represented the underwriters. BioAge Labs, Inc., a clinical-stage biopharmaceutical company (Nasdaq: BIOA), has completed an...
Juvena Therapeutics Secures $33.5 Million in Series B Financing
Fenwick & West and Wilson Sonsini Goodrich & Rosati have advised Juvena Therapeutics. Juvena Therapeutics, a clinical-stage biotechnology company, has raised $33.5 million in a Series...
EpiBiologics Secures $107 Million in Series B Funding to Advance Antibody Pipeline
Fenwick & West has advised EpiBiologics. EpiBiologics, a company specializing in tissue-selective extracellular protein degradation, has completed a $107 million Series B financing round. The funding...
Jupiter Endovascular Secures $40 Million in Series B Funding
Fenwick & West has advised Jupiter Endovascular on the transaction. Jupiter Endovascular, a medical technology startup specializing in endovascular procedures, has completed a Series B financing...
CorMedix Acquires Melinta Therapeutics in $300 Million Deal
Fenwick & West LLP has advised Melinta Therapeutics on the transaction, and Katten Muchin Rosenman LLP has advised Deerfield Management Company, L.P. Melinta Therapeutics, a commercial-stage...
Lyra Health Acquires Bend Health to Expand Pediatric Services
Fenwick & West has advised Lyra Health on the transaction. Lyra Health, a leading provider of mental health benefits for employers, has announced the acquisition of...
Akido Labs’ $60 Million Series B Funding Round
Fenwick & West represented Akido Labs in the transaction. Akido Labs (“Akido”), an AI and healthcare delivery company, announced raising $60 million in Series B funding...
Attovia Therapeutics’ $90 Million Series C Funding Round
Fenwick & West represented Attovia Therapeutics in the transaction. Attovia Therapeutics, a clinical-stage biopharma company developing treatments for immune-mediated diseases, announced it raised $90 million in...
BioAge Labs’ $238 Million Upsized Initial Public Offering
Fenwick & West represented BioAge Labs, Inc. in the offering, and Cooley represented the underwriters. BioAge Labs, Inc. (Nasdaq: BIOA), a clinical-stage biopharmaceutical company developing therapeutic...
Elegen’s $35 Million Series B Financing Round
Fenwick & West represented Elegen in the transaction. Elegen announced it raised $35 million in Series B Financing Round led by Triatomic Capital and was joined...
Attovia Therapeutics’ $105 Million Oversubscribed Series B Financing
Fenwick & West represented Attovia Therapeutics in the transaction. Attovia Therapeutics (“Attovia”), a developer of a pipeline of biotherapeutics with an initial focus on immune-mediated diseases,...